ATRIUM HEALTH NAVICENT THE MEDICAL CENTER

45 CFR § 180 compliance

F · 55

This hospital published little of what § 180 requires.

●Machine-readable file published

○Gross / standard charges

○Discounted cash price

●Payer-specific negotiated rates

○Min / max negotiated charges

●Free, public, no login required

Procedures listed

6,498

Insurances with rates

CPT / HCPCS codes

6,253

Source MRF

csv ↗

Most expensive procedures (gross)

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
J2326	NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION	$1,482,459	$741,229	—	—	4
J1305	EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION	$453,486	$226,743	—	—	5
C9293	GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION	$442,646	$221,323	—	—	2
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$328,506	$164,253	—	—	1
J9269	TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION	$312,299	$156,150	—	—	1
J3357	USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE	$303,977	$151,988	—	—	3
J9348	NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION	$280,233	$140,117	—	—	2
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$221,915	$110,958	—	—	2
J9274	TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION	$189,490	$94,745	—	—	4
J1303	RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION	$185,645	$92,822	—	—	8
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN	$172,951	$86,475	—	—	3
J9266	PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION	$172,113	$86,056	—	—	1
J0202	ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION	$163,202	$81,601	—	—	1
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE	$151,989	$75,994	—	—	3
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$139,906	$69,953	—	—	4
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$132,868	$66,434	—	—	2
J9038	AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION	$124,188	$62,094	—	—	4
J1744	ICATIBANT 30 MG/3 ML SUBCUTANEOUS SYRINGE	$119,836	$59,918	—	—	15
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$119,458	$59,729	—	—	2
J9382	ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION	$109,894	$54,947	—	—	6
J2840	SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION	$109,783	$54,891	—	—	2
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$109,148	$54,574	—	—	1
J9307	PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION	$108,840	$54,420	—	—	5
J0222	PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION	$105,214	$52,607	—	—	2
J9022	ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION	$104,129	$52,065	—	—	3
J2267	MIRIKIZUMAB-MRKZ 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION	$103,152	$51,576	—	—	4
J9119	CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION	$98,163	$49,081	—	—	2
J2323	NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION	$91,805	$45,903	—	—	4
J2997	ALTEPLASE 100 MG INTRAVENOUS SOLUTION	$91,791	$45,895	—	—	5
J1930	LANREOTIDE 90 MG/0.3 ML SUBCUTANEOUS SYRINGE	$87,161	$43,581	—	—	2
J9228	IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION	$82,164	$41,082	—	—	1
J9301	OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION	$79,718	$39,859	—	—	1
J9325	TALIMOGENE LAHERPAREPVEC 10EXP8 (100 MILLION)PFU/ML SUSP FOR INJECTION	$75,090	$37,545	—	—	0
J2427	PALIPERIDONE PALMITATE (3 MONTH) 546 MG/1.75 ML INTRAMUSCULAR SYRINGE	$72,948	$36,474	—	—	6
J9022	ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION	$72,906	$36,453	—	—	2
J9210	EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION	$71,833	$35,916	—	—	4
J9063	MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION	$71,331	$35,666	—	—	3
J1323	ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION	$69,940	$34,970	—	—	9
J0584	BUROSUMAB-TWZA 20 MG/ML SUBCUTANEOUS SOLUTION	$66,892	$33,446	—	—	8
J9332	EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION	$66,572	$33,286	—	—	2
J9333	ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION	$65,876	$32,938	—	—	5
J9303	PANITUMUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION	$65,064	$32,532	—	—	3
J9306	PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION	$63,140	$31,570	—	—	5
J9307	PRALATREXATE 20 MG/ML (1 ML) INTRAVENOUS SOLUTION	$62,835	$31,417	—	—	2
J1932	LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE	$62,612	$31,306	—	—	2
J1299	ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION	$60,388	$30,194	—	—	1
J0517	BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE	$55,627	$27,814	—	—	2
J2427	PALIPERIDONE PALMITATE (3 MONTH) 410 MG/1.32 ML INTRAMUSCULAR SYRINGE	$54,709	$27,354	—	—	2
J2267	MIRIKIZUMAB-MRKZ 100 MG/ML SUBCUTANEOUS PEN INJECTOR	$54,058	$27,029	—	—	9
J9271	PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION	$53,534	$26,767	—	—	4

Showing top 50 of 6,498 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.